Using nailfold capillaroscopy to assess the effectiveness of ongoing therapy (dupilumab) in a patient with severe bronchial asthma
P. V. Berezhanskiy,
A. E. Khurgaeva,
A. B. Malakhov,
T. A. Gutyrchik,
S. I. Shatalina,
N. G. Kolosova https://doi.org/10.31146/2949-4664-apps-3-2-58-65
Abstract
Bronchial asthma remains a pressing public health issue due to its high prevalence, increasing incidence, and serious eco- nomic burden. Timely diagnosis, identifiation of predictors of the disease development, as well as assessment of treatment effectiveness are key factors for early detection, prevention of asthma progression, reduction of complication risk, and the development of personalized therapy, improving patients’ quality of life. We demonstrated the prospects and practical significance of using a microcirculation imaging method for disease diagnosis, as well as for assessing the effectiveness of biological therapy (dupilumab) in a patient with severe bronchial asthma.
About the Authors
P. V. Berezhanskiy
Clinical Research Institute for Childhood Diseases, Moscow Region Ministry of Health; Morozovskaya Children’s City Clinical Hospital; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University); Peoples’ Friendship University of Russia named after Patrice Lumumba
Russian Federation
Russian Federation
Pavel V. Berezhanskiy – Dr. Sci. (Med.), Senior Researcher, Department of Pediatrics; Pediatrician, Pulmonology department; Prof., Department of Pediatric Diseases, N.F. Filatov Clinical Institute of Child Health; Assoc. Prof., Department of Clinical Immunology, Allergology and Adaptology
24A, bldg. 1, Kominterna str., Mytishchi,141009
1/9, 4th Dobryninsky Lane, Moscow, 119049
19, bldg. 1, Bolshaya Pirogovskaya str., Moscow, 119991
6, Miklukho-Maklaya str., Moscow, 117189
A. E. Khurgaeva
Morozovskaya Children’s City Clinical Hospital
Russian Federation
Russian Federation
Anastasia E. Khurgaeva – Pediatrician
1/9, 4th Dobryninsky Lane, Moscow, 119049
A. B. Malakhov
Clinical Research Institute for Childhood Diseases, Moscow Region Ministry of Health; Morozovskaya Children’s City Clinical Hospital; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Russian Federation
Alexander B. Malakhov – Dr. Sci. (Med.), Head of Pediatrics Department; Pulmonologist, Department of pulmonology; Prof., Department of Pediatric Diseases, N.F. Filatov Clinical Institute of Child Health; Chief freelance pediatric pulmonologist, Moscow Department of Health and Moscow Region Ministry of Health
24A, bldg. 1, Kominterna str., Mytishchi,141009
1/9, 4th Dobryninsky Lane, Moscow, 119049
19, bldg. 1, Bolshaya Pirogovskaya str., Moscow, 119991
T. A. Gutyrchik
Morozovskaya Children’s City Clinical Hospital
Russian Federation
Russian Federation
Tatyana A. Gutyrchik – Pediatrician, Pulmonologist, Department of pulmonology
1/9, 4th Dobryninsky Lane, Moscow, 119049
S. I. Shatalina
Clinical Research Institute for Childhood Diseases, Moscow Region Ministry of Health; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Russian Federation
Svetlana I. Shatalina – Senior Researcher, Pediatrics Department; Cand. Sci. (Med.), Assist. Prof., Department of Pediatric Diseases, N.F. Filatov Clinical Institute of Child Health
24A, bldg. 1, Kominterna str., Mytishchi, 141009
19, bldg. 1, Bolshaya Pirogovskaya str., Moscow, 119991
N. G. Kolosova
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Russian Federation
Natalia G. Kolosova – Cand. Sci. (Med.), Assoc. Prof., Department of Pediatric Diseases, N.F. Filatov Clinical Institute of Child Health
19, bldg. 1, Bolshaya Pirogovskaya str., Moscow, 119991
References
1. Global Initiative for Asthma Global strategy for asthma management and prevention, 2024. https://ginasthma.org/2024-report.
2. Clinical recommendations «Bronchial asthma. Age group: children/adults». 20.02.2024 (approved by the Russian Ministry of Health) (In Russ.).
3. Gans M.D., Gavrilova Т. Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes. Paediatr Respir Rev. 2020;36:118–127. doi: 10.1016/j.prrv.2019.08.002.
4. Berezhansky P.V., Gutyrchik T.A., Malakhov A.B., Kovalenko I.V. et al. Features of changes in the microcirculatory system in children with a history of severe allergic anamnesis. Pediatrics. Consilium Medicum. 2022;4:344–348. (In Russ.). doi: 10.26442/26586630.2022.4.202001.
5. Chumovatov N.V., Zakharov A.V., Chernykh N.A., Romanov V.V. Clinical and diagnostic possibilities of capillaroscopy of the nail bed and prospects of application of the method in phthisiology and pulmonology. Bulletin of the Central Scientific Research Institute of Tuberculosis. 2024;8(2):5–12. (In Russ.).
6. Ryvkin A.I., Andrianova E.N., Pobedinskaya N.S., Reshetova T.G. et al. Th e state of microhemocirculation in children with bronchial asthma. Pediatrics. Th e G.N. Speransky Journal. 2006;85(6):7–11.
7. Landyshev Yu.S., Bazilevich A.Yu., Chalenko T.N. Th e role of rheopulmonography in evaluating the effectiveness of basic therapy for bronchial asthma. Bulletin of physiology and pathology of respiration. 2004;17:45–48. (In Russ.).
8. Tavakol M.E., Fatemi A., Karbalaie A., et al. Nailfold capillaroscopy in rheumatic diseases: which parameters should be evaluated? Biomed. Res. Int. 2015;974530. doi: 10.1155/2015/974530.
9. Park H.S., Kim S.Y., Kim S.R. Targeting abnormal airway vascularity as a therapeutical strategy in asthma. Respirology. 2019;15(3):458–471. doi: 10.1111/j.1440-1843.2010.01724.x.
10. Krylova O.Y, Pirogov A.B., Kolosov V.P. Arteriocapillary blood flow in the lungs and pulmonary hypertension in patients with bronchial asthma. Pulmonology. 2009;3:71–74. (In Russ.). doi: 10.18093/0869-0189-2009-3-71-74.
11. Petry D.G, Terreri М.Т, Len С.А. Nailfoldcapillaroscopy in children and adolescents. ActaReumatol. Port. 2008;33(4):395–400.
12. Berezhansky P.V., Gutyrchik T.A., Melnikova I.M., Malakhov A.B. et al. A method for predicting the risk of developing bronchial asthma in children 7 years and younger with a history of severe allergies. (In Russ.). Patent for invention No. 2789970, Russian Federation, C1, IPC A61B 5/08.
13. Howell I., Howell A., Pavord I.D. Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight. Experimental Medicine Division. 2023;7(220). doi: 10.1084/jem.20221212.
14. Geppe N.A., Kolosova N.G., Kondyurina E.G., Malakhov A.B., Mizernitsky Yu.L., Revyakina V.A. National program «Bronchial asthma in children. Treatment strategy and prevention». 2017. (In Russ.).
15. Schoettler N., Strek M.E. Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine. Chest. 2020;157(3):516–528. doi: 10.1016/j.chest.2019.10.009.
16. Avdeev S.N., Nenasheva N.M., Zhudenkov K.V. Prevalence, incidence, phenotypes and other characteristics of severe bronchial asthma in the Russian Federation. Pulmonology. 2018;28(3):341-358. (In Russ.). doi: 10.18093/0869-0189-2018-28-3-341-358.
17. Ivakhnenko I.V., Kolesnikova I.Y. Tactics of management of patients with exacerbation of bronchial asthma. Medicinal bulletin. 2020;14(4):20–28. (In Russ.).
18. Kardas G., Kuna P., Panek M. Biological therapies of severe asthma and their possible effects on airway remodeling. Front. Immunol. 2020;11:1–11. doi: 10.3389/fimmu.2020.01134.
19. Sastre J., Dávila I. Dupilumab: a new paradigm for the treatment of allergic diseases. Journal of investigational allergology and clinical immunology. 2018;28(3):139–150. doi: 10.18176/jiaci.0254.
20. Castro M., Corren J., Pavord I.D., Maspero J., Wenzel S., Rabe K.F., et al. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma. New England journal of medicine. 2018;378(26):2486–2496. doi: 10.1056/NEJMoa1804092.
21. Revyakina V.A., Geppe N.A. Practical recommendations for the use of biological drugs in complex (comorbid) patients with allergic and autoimmune diseases. Moscow: «MedCom-Pro», 2024. (In Russ.).
Review
For citations:
Berezhanskiy P.V., Khurgaeva A.E., Malakhov A.B., Gutyrchik T.A., Shatalina S.I., Kolosova N.G. Using nailfold capillaroscopy to assess the effectiveness of ongoing therapy (dupilumab) in a patient with severe bronchial asthma. Archives of Pediatrics and Pediatric Surgery. 2025;3(2):58-65. (In Russ.) https://doi.org/10.31146/2949-4664-apps-3-2-58-65
Views:
56
JATS XML
Email this article 